Cartesian Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-09-30 was $82.00K, a 32.26% increase year-over-year.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $149.00K, a 17.32% increase year-over-year.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-09-30 was $62.00K, a 30.34% decline year-over-year.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-03-31 was $127.00K, a 76.39% increase year-over-year.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $231.00K, a 22.22% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $189.00K, a 17.39% increase from fiscal 2021.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $161.00K, a 12.50% decline from fiscal 2020.
- Cartesian Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2020 was $184.00K, a 557.14% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2023-12-31 | $231.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $82.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $149.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $189.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $62.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $127.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $161.00K 10-K · filed 2024-03-07 | |
| 2021-09-30 | $89.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $72.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $184.00K 10-K · filed 2023-03-02 | |
| 2020-09-30 | $70.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $114.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $28.00K 10-K · filed 2022-03-10 | |
| 2019-09-30 | $8.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $20.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $196.00K 10-K · filed 2021-03-12 | |
| 2018-09-30 | $145.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $51.00K 10-Q · filed 2019-11-08 | $231.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $180.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |